Genmab A/S, the Danish developer of cancer drugs, rose to the highest price in more than four years in Copenhagen trading on bets its leukemia treatment will be able to match a competing product from Roche Holding AG.
Matas A/S, the Danish drugstore chain that held an initial public offering in June, rose the most since its first day of trading in Copenhagen, as three banks recommended buying the stock due to its dividend yield.
A.P. Moeller-Maersk A/S, owner of the world’s largest container line, rose the most in more than two weeks in Copenhagen trading after Goldman Sachs Group Inc. said investors should buy the stock as cost cuts boost profits.
Vestjysk Bank A/S, which last year fired its chief executive officer as loan losses surged, fell the most in five months in Copenhagen trading after Danske Markets said recent share gains were overdone.
Ringkjoebing Landbobank A/S, a Danish regional lender that has reported profits in the past 18 quarters, rose to a six-year high in Copenhagen after Nordea Markets and Danske Markets raised price estimates on the share.
Veloxis Pharmaceuticals A/S fell the most in 11 days in Copenhagen trading after Danske Markets said the Danish maker of treatments for organ transplant patents faces pressure from a rival product by Astellas Pharma Inc.
FLSmidth & Co. A/S rose the most among Copenhagen’s benchmark stocks today after two of Denmark’s biggest banks raised price estimates on bets the maker of mining equipment’s cost-cutting plan will improve profits.